Peptide Library
A structured peptide library that separates FDA-approved drugs, investigational compounds, and research-market names instead of flattening them into one hype-heavy list.
80
Profiles
13
FDA Approved
20
Investigational
46
Research Market
Browse the library
Find compounds by category, status, or name
Use quick category chips to narrow the library, or search by compound, alias, or mechanism. The page keeps the editorial category structure but collapses anything that does not match.
`FDA`, `Trials`, and `PubMed` badges are automated context indicators generated from official/public data sources. They help show whether a peptide has label, study, or literature signal, but they do not prove efficacy, safety, approval status outside the labeled context, or product quality.
⚖️
Weight Loss Peptides
18 profiles
GLP-1 agonists, dual agonists, triple agonists, and metabolic compounds tied to body-composition demand.
💪
Muscle Growth Peptides
13 profiles
Performance-adjacent peptides and growth-factor analogs that usually live outside standard medical use.
🩹
Recovery & Healing
10 profiles
Tissue-repair, soft-tissue, and gut-oriented peptides that show up constantly in injury-recovery discussions.
🧬
Anti-Aging Peptides
5 profiles
Longevity-facing compounds where mechanism, speculation, and marketing often collide.
✨
Skin & Cosmetic
7 profiles
Copper peptides, regenerative signaling compounds, and dermal-facing entries with cosmetic crossover.
📈
Growth Hormone
10 profiles
GHRH analogs and secretagogues that sit in the GH-optimization corner of the peptide market.
🧠
Nootropic Peptides
5 profiles
Cognitive and neuropeptide-oriented compounds that are popular online but often weakly explained.
🛡️
Immune & Inflammation
11 profiles
Immune-oriented peptides with more clinical framing than the average research-market profile.
🧪
Hormone Peptides
26 profiles
Hormone-linked signaling compounds that do not fit cleanly into the GH or metabolic buckets.
•
Other Peptides
12 profiles
Useful overflow for compounds that do not belong to the main editorial buckets.
⚖️ Weight Loss Peptides
Weight Loss
GLP-1 agonists, dual agonists, triple agonists, and metabolic compounds tied to body-composition demand.
18
🔥 HOT
Weight Loss
Amycretin
A Novo Nordisk investigational co-agonist targeting GLP-1 and amylin pathways, now closely watched as a next-wave obesity candidate.
Investigational Promising evidence 1 alias
Also in Hormone
Trials 21PubMed 17 Medium context
🔥 HOT
Weight Loss
Cagrilintide
A long-acting amylin analogue often discussed alongside GLP-1 therapies in obesity-drug development.
Investigational Promising evidence
Trials 43PubMed 86 Medium context
🔥 HOT
Weight Loss
CagriSema
A Novo Nordisk investigational combination of cagrilintide and semaglutide, designed to pair amylin and GLP-1 pathways in obesity.
Investigational Promising evidence
Also in Hormone
Trials 30PubMed 44 Medium context
🔥 HOT
Weight Loss
Eloralintide
A selective amylin receptor agonist from Eli Lilly that has moved into Phase 3 obesity trials.
Investigational Promising evidence 1 alias
Also in Hormone
Trials 18PubMed 6 Medium context
🔥 HOT
Weight Loss
Mazdutide
A GLP-1 and glucagon dual agonist developed with Innovent and Lilly, notable for obesity data and approval progress in China.
Investigational Promising evidence 2 aliases
Also in Hormone
Trials 36PubMed 46 Medium context
🔥 HOT
Weight Loss
Pemvidutide
A balanced GLP-1 and glucagon dual agonist from Altimmune with obesity and liver-disease relevance.
Investigational Promising evidence 1 alias
Also in Hormone
Trials 15PubMed 15 Medium context
🔥 HOT
Weight Loss
Petrelintide
A long-acting amylin analog from Zealand Pharma being developed for obesity and overweight.
Investigational Promising evidence
Also in Hormone
Trials 6PubMed 4 Low context
🔥 HOT
Weight Loss
Retatrutide
A next-generation triple agonist targeting GLP-1, GIP, and glucagon receptors, showing unprecedented 24.2% weight loss in clinical trials. Expected FDA approval in 2027.
Investigational Promising evidence 1 alias
Trials 35PubMed 157 Medium context
🔥 HOT
Weight Loss
Semaglutide
A GLP-1 receptor agonist used in FDA-approved products for type 2 diabetes, chronic weight management, and additional labeled uses depending on brand and indication.
FDA Approved Established evidence 3 aliases
FDATrials 742PubMed 5.1K High context
🔥 HOT
Weight Loss
Survodutide
An investigational dual-agonist obesity and metabolic-disease candidate that shows up in next-wave incretin discussions.
Investigational Promising evidence
Trials 24PubMed 67 Medium context
🔥 HOT
Weight Loss
Tirzepatide
A dual GIP and GLP-1 receptor agonist used in FDA-approved products for type 2 diabetes and chronic weight management.
FDA Approved Established evidence 2 aliases
FDATrials 272PubMed 2.2K High context
Weight Loss
Adipotide
A peptidomimetic that targets prohibitin on the vasculature of white adipose tissue, inducing apoptosis of fat cells and rapid weight loss in primate models.
Research Market Preclinical evidence 2 aliases
Also in Metabolic
Trials 2PubMed 19 Low context
Weight Loss
AOD-9604
A modified fragment of human growth hormone discussed in weight-management and fat-metabolism circles, but not approved as an FDA drug.
Research Market Preclinical evidence 1 alias
PubMed 12 Low context
Anti-Aging
Humanin
A mitochondria-associated peptide frequently discussed in longevity circles for cytoprotective and metabolic-interest pathways.
Research Market Preclinical evidence
Also in Weight Loss
Trials 7PubMed 527 Medium context
Anti-Aging
MOTS-c
A mitochondria-derived peptide studied in metabolic and exercise-related aging discussions.
Research Market Promising evidence 1 alias
Also in Weight Loss
Trials 8PubMed 246 Medium context
Weight Loss
Oxyntomodulin
A gut hormone that acts on GLP-1 and glucagon-related pathways and helped shape the modern obesity-peptide conversation.
Investigational Early evidence 1 alias
Also in Hormone
Trials 54PubMed 493 Medium context
Weight Loss
Peptide YY
A satiety-linked gut hormone that has long been studied in obesity and appetite regulation.
Investigational Promising evidence 2 aliases
Also in Hormone
Trials 708PubMed 4.4K Medium context
Weight Loss
Setmelanotide
An FDA-approved MC4R agonist marketed as Imcivree for specific rare genetic forms of obesity.
FDA Approved Established evidence 2 aliases
Also in Hormone
FDATrials 30PubMed 205 High context
💪 Muscle Growth Peptides
Muscle Growth
Performance-adjacent peptides and growth-factor analogs that usually live outside standard medical use.
13
🔥 HOT
Muscle Growth
Follistatin 344
A myostatin-linked muscle-growth name that remains popular in research-market and performance discussions despite limited conventional therapeutic development.
Research Market Promising evidence 2 aliases
Also in Other
Trials 75PubMed 2.9K Medium context
Recovery
BPC-157
A 15-amino acid peptide derived from human gastric juice, extensively studied for tissue regeneration, gut healing, and injury recovery across multiple systems.
Research Market Early evidence 2 aliases
Also in Muscle Growth
Trials 2PubMed 214 Low context
Growth Hormone
CJC-1295
A GHRH analog commonly discussed in growth-hormone optimization circles and research-market peptide stacks.
Research Market Promising evidence 1 alias
Also in Muscle Growth
Trials 1PubMed 32 Low context
Growth Hormone
GHRP-2
A growth hormone secretagogue that appears in older GH-optimization discussions and research-market listings.
Research Market Preclinical evidence
Also in Muscle Growth
PubMed 204 Low context
Growth Hormone
GHRP-6
A classic growth hormone secretagogue that remains common in peptide-market catalogs despite limited mainstream clinical relevance.
Research Market Preclinical evidence
Also in Muscle Growth
PubMed 634 Low context
Muscle Growth
IGF-1 DES
A truncated IGF-1 analog that remains a familiar name in performance and tissue-growth peptide discussions.
Research Market Preclinical evidence 1 alias
Also in Growth Hormone
PubMed 6 Low context
Muscle Growth
IGF-1 LR3
A long-acting insulin-like growth factor analog discussed in physique and performance communities rather than approved peptide medicine.
Research Market Preclinical evidence 1 alias
Also in Growth Hormone
PubMed 17 Low context
Growth Hormone
Ipamorelin
A ghrelin-mimetic growth hormone secretagogue often paired with CJC-1295 in research-market discussions.
Research Market Promising evidence
Also in Muscle Growth
Trials 2PubMed 49 Low context
Muscle Growth
PEG-MGF
A pegylated mechano growth factor analogue often discussed in performance and recovery circles.
Research Market Preclinical evidence 2 aliases
Also in Growth Hormone
Trials 485PubMed 194 Medium context
Growth Hormone
Sermorelin
A GHRH analogue with older clinical and diagnostic history that now appears frequently in the research and wellness peptide market.
Research Market Preclinical evidence 2 aliases
Also in Muscle Growth
Trials 42PubMed 33 Medium context
Metabolic
SLU-PP-332
A small-molecule ERRα/γ agonist studied as an exercise mimetic, shown to increase oxidative muscle fiber composition and endurance capacity in preclinical models.
Research Market Preclinical evidence 1 alias
Also in Muscle Growth
PubMed 10 Low context
Recovery
TB-500
A synthetic version of the active region of thymosin beta-4, commonly discussed for soft-tissue recovery and injury support.
Research Market Promising evidence 1 alias
Also in Muscle Growth
Trials 19PubMed 736 Medium context
Growth Hormone
Tesamorelin
A growth hormone-releasing hormone analog approved in the United States for reducing excess abdominal fat in certain adults with HIV-associated lipodystrophy.
FDA Approved Established evidence 2 aliases
Also in Muscle Growth
FDATrials 24PubMed 93 High context
🩹 Recovery & Healing
Recovery
Tissue-repair, soft-tissue, and gut-oriented peptides that show up constantly in injury-recovery discussions.
10
Recovery
AHK-Cu
A copper-binding tripeptide (Ala-His-Lys-Cu) studied for hair follicle stimulation and wound healing, structurally related to GHK-Cu but with a different amino acid sequence.
Research Market Preclinical evidence 2 aliases
Also in Skin & Cosmetic
PubMed 1 Low context
Recovery
ARA-290
An erythropoietin-derived peptide fragment studied for tissue-protective and neuropathy-related applications without the red-blood-cell effects of full EPO.
Investigational Promising evidence 1 alias
Trials 4PubMed 77 Medium context
Recovery
BPC-157
A 15-amino acid peptide derived from human gastric juice, extensively studied for tissue regeneration, gut healing, and injury recovery across multiple systems.
Research Market Early evidence 2 aliases
Also in Muscle Growth
Trials 2PubMed 214 Low context
Recovery
Cartalax
A synthetic tripeptide (Ala-Glu-Asp) from the Khavinson bioregulator family, studied for cartilage-protective and geroprotective effects in preclinical models.
Research Market Promising evidence 2 aliases
Also in Longevity
Trials 285PubMed 8.1K Medium context
Skin & Cosmetic
GHK-Cu
A copper-binding peptide used in cosmetic and wound-healing discussions, especially around skin appearance and tissue signaling.
Research Market Promising evidence 1 alias
Also in Recovery
Trials 1PubMed 83 Low context
Recovery
Glutathione
A tripeptide antioxidant composed of glutamate, cysteine, and glycine, central to cellular detoxification, immune function, and oxidative stress defense.
FDA Approved (Compounding) Early evidence 3 aliases
Also in Anti-Aging
Trials 1.5KPubMed 195.5K Medium context
Recovery
KPV
A short peptide fragment associated with gut-barrier, inflammatory, and tissue-soothing discussions in the peptide market.
Research Market Preclinical evidence
Also in Immune · Skin & Cosmetic
PubMed 132 Low context
Longevity
NAD+
Nicotinamide adenine dinucleotide, a coenzyme central to cellular energy metabolism and DNA repair, studied for age-related decline and its role in sirtuin activation.
Research Market Promising evidence 2 aliases
Also in Metabolic · Recovery
Trials 732PubMed 57.6K Medium context
Anti-Aging
SS-31
A mitochondria-targeted peptide studied for cellular energy and tissue-protection questions.
Investigational Promising evidence 1 alias
Also in Recovery
Trials 32PubMed 452 Medium context
Recovery
TB-500
A synthetic version of the active region of thymosin beta-4, commonly discussed for soft-tissue recovery and injury support.
Research Market Promising evidence 1 alias
Also in Muscle Growth
Trials 19PubMed 736 Medium context
🧬 Anti-Aging Peptides
Anti-Aging
Longevity-facing compounds where mechanism, speculation, and marketing often collide.
5
Anti-Aging
Epitalon
A short peptide associated with longevity and telomere-oriented anti-aging discussion in the research market.
Research Market Preclinical evidence 1 alias
PubMed 119 Low context
Recovery
Glutathione
A tripeptide antioxidant composed of glutamate, cysteine, and glycine, central to cellular detoxification, immune function, and oxidative stress defense.
FDA Approved (Compounding) Early evidence 3 aliases
Also in Anti-Aging
Trials 1.5KPubMed 195.5K Medium context
Anti-Aging
Humanin
A mitochondria-associated peptide frequently discussed in longevity circles for cytoprotective and metabolic-interest pathways.
Research Market Preclinical evidence
Also in Weight Loss
Trials 7PubMed 527 Medium context
Anti-Aging
MOTS-c
A mitochondria-derived peptide studied in metabolic and exercise-related aging discussions.
Research Market Promising evidence 1 alias
Also in Weight Loss
Trials 8PubMed 246 Medium context
Anti-Aging
SS-31
A mitochondria-targeted peptide studied for cellular energy and tissue-protection questions.
Investigational Promising evidence 1 alias
Also in Recovery
Trials 32PubMed 452 Medium context
✨ Skin & Cosmetic
Skin & Cosmetic
Copper peptides, regenerative signaling compounds, and dermal-facing entries with cosmetic crossover.
7
Recovery
AHK-Cu
A copper-binding tripeptide (Ala-His-Lys-Cu) studied for hair follicle stimulation and wound healing, structurally related to GHK-Cu but with a different amino acid sequence.
Research Market Preclinical evidence 2 aliases
Also in Skin & Cosmetic
PubMed 1 Low context
Skin & Cosmetic
GHK-Cu
A copper-binding peptide used in cosmetic and wound-healing discussions, especially around skin appearance and tissue signaling.
Research Market Promising evidence 1 alias
Also in Recovery
Trials 1PubMed 83 Low context
Recovery
KPV
A short peptide fragment associated with gut-barrier, inflammatory, and tissue-soothing discussions in the peptide market.
Research Market Preclinical evidence
Also in Immune · Skin & Cosmetic
PubMed 132 Low context
Skin & Cosmetic
Melanotan I
A melanocortin peptide analogue tied to pigmentation and photoprotection research, and closely related to the approved drug afamelanotide.
FDA Approved Established evidence 2 aliases
Also in Hormone
FDATrials 23PubMed 119 High context
Skin & Cosmetic
Melanotan II
A melanocortin analogue commonly discussed for tanning and cosmetic interest but not approved as an FDA drug.
Research Market Promising evidence
Also in Hormone
Trials 1PubMed 197 Low context
Hormone
PT-141
A melanocortin peptide best known in regulated medicine as bremelanotide and in the research market as PT-141.
FDA Approved Established evidence 2 aliases
Also in Skin & Cosmetic
FDATrials 10PubMed 111 High context
Skin & Cosmetic
SNAP-8
A cosmetic-facing peptide often discussed in topical anti-wrinkle and expression-line products.
Research Market Anecdotal evidence 1 alias
📈 Growth Hormone
Growth Hormone
GHRH analogs and secretagogues that sit in the GH-optimization corner of the peptide market.
10
Growth Hormone
CJC-1295
A GHRH analog commonly discussed in growth-hormone optimization circles and research-market peptide stacks.
Research Market Promising evidence 1 alias
Also in Muscle Growth
Trials 1PubMed 32 Low context
Growth Hormone
GHRP-2
A growth hormone secretagogue that appears in older GH-optimization discussions and research-market listings.
Research Market Preclinical evidence
Also in Muscle Growth
PubMed 204 Low context
Growth Hormone
GHRP-6
A classic growth hormone secretagogue that remains common in peptide-market catalogs despite limited mainstream clinical relevance.
Research Market Preclinical evidence
Also in Muscle Growth
PubMed 634 Low context
Growth Hormone
Hexarelin
A growth hormone secretagogue and ghrelin-receptor agonist that remains a familiar legacy name in GH-peptide stacks.
Research Market Preclinical evidence
Also in Hormone
PubMed 289 Low context
Muscle Growth
IGF-1 DES
A truncated IGF-1 analog that remains a familiar name in performance and tissue-growth peptide discussions.
Research Market Preclinical evidence 1 alias
Also in Growth Hormone
PubMed 6 Low context
Muscle Growth
IGF-1 LR3
A long-acting insulin-like growth factor analog discussed in physique and performance communities rather than approved peptide medicine.
Research Market Preclinical evidence 1 alias
Also in Growth Hormone
PubMed 17 Low context
Growth Hormone
Ipamorelin
A ghrelin-mimetic growth hormone secretagogue often paired with CJC-1295 in research-market discussions.
Research Market Promising evidence
Also in Muscle Growth
Trials 2PubMed 49 Low context
Muscle Growth
PEG-MGF
A pegylated mechano growth factor analogue often discussed in performance and recovery circles.
Research Market Preclinical evidence 2 aliases
Also in Growth Hormone
Trials 485PubMed 194 Medium context
Growth Hormone
Sermorelin
A GHRH analogue with older clinical and diagnostic history that now appears frequently in the research and wellness peptide market.
Research Market Preclinical evidence 2 aliases
Also in Muscle Growth
Trials 42PubMed 33 Medium context
Growth Hormone
Tesamorelin
A growth hormone-releasing hormone analog approved in the United States for reducing excess abdominal fat in certain adults with HIV-associated lipodystrophy.
FDA Approved Established evidence 2 aliases
Also in Muscle Growth
FDATrials 24PubMed 93 High context
🧠 Nootropic Peptides
Nootropic
Cognitive and neuropeptide-oriented compounds that are popular online but often weakly explained.
5
🔥 HOT
Nootropic
Dihexa
A high-curiosity neurotrophic research peptide discussed for cognition and synaptogenesis, but still lacking real clinical development.
Research Market Preclinical evidence 2 aliases
Also in Other
PubMed 17 Low context
Nootropic
DSIP
A peptide discussed for sleep-related and neuroregulatory interest, though its evidence base is far less concrete than vendor listings suggest.
Research Market Preclinical evidence 1 alias
PubMed 462 Low context
Nootropic
NA-Semax Amidate
An N-acetylated, amidated form of Semax designed for enhanced stability, studied for nootropic and neuroprotective effects via BDNF upregulation and melanocortin receptor activity.
Research Market Preclinical evidence 2 aliases
Also in Neuroprotection
Trials 63PubMed 21 Medium context
Nootropic
Selank
A synthetic peptide associated with anxiolytic and cognitive-interest discussions in nootropic communities.
Research Market Preclinical evidence
Also in Immune
Trials 10PubMed 68 Medium context
Nootropic
Semax
A synthetic neuropeptide analog often discussed for cognitive and neuroprotection-related interest in research-market circles.
Research Market Preclinical evidence
Also in Immune
PubMed 399 Low context
🛡️ Immune & Inflammation
Immune
Immune-oriented peptides with more clinical framing than the average research-market profile.
11
Other
Cortistatin
A neuropeptide related to somatostatin that has been studied for anti-inflammatory, neuroendocrine, and cardiovascular effects.
Investigational Preclinical evidence 1 alias
Also in Hormone · Immune
Trials 727PubMed 8K Medium context
Recovery
KPV
A short peptide fragment associated with gut-barrier, inflammatory, and tissue-soothing discussions in the peptide market.
Research Market Preclinical evidence
Also in Immune · Skin & Cosmetic
PubMed 132 Low context
Immune
LL-37
A host-defense peptide associated with innate immunity and tissue-response discussions.
Research Market Promising evidence
Trials 98PubMed 4.3K Medium context
Neuroprotection
NA-Selank Amidate
An N-acetylated, amidated form of Selank designed for enhanced stability and nasal bioavailability, studied for anxiolytic and nootropic effects via tuftsin-related immune modulation.
Research Market Preclinical evidence 2 aliases
Also in Immune
Trials 449PubMed 15.8K Medium context
Nootropic
Selank
A synthetic peptide associated with anxiolytic and cognitive-interest discussions in nootropic communities.
Research Market Preclinical evidence
Also in Immune
Trials 10PubMed 68 Medium context
Nootropic
Semax
A synthetic neuropeptide analog often discussed for cognitive and neuroprotection-related interest in research-market circles.
Research Market Preclinical evidence
Also in Immune
PubMed 399 Low context
Immune
Thymagen
A synthetic dipeptide (Glu-Trp) from the Khavinson bioregulator family, studied for thymic bioregulation and immune system support in aging.
Research Market Preclinical evidence 3 aliases
Also in Longevity
Trials 207PubMed 3.2K Medium context
Immune
Thymalin
A thymus-derived peptide complex often discussed in immune and longevity circles.
Research Market Preclinical evidence
PubMed 234 Low context
Immune
Thymosin Alpha-1
An immune-oriented peptide discussed for immunomodulatory signaling and clinical research in infectious disease and oncology-adjacent contexts.
Investigational Promising evidence 2 aliases
Trials 78PubMed 1.3K Medium context
Immune
Vilon
A synthetic dipeptide (Lys-Glu) from the Khavinson bioregulator family, studied for thymic and immune system bioregulation and geroprotective effects.
Research Market Preclinical evidence 2 aliases
Also in Longevity
Trials 748PubMed 4.7K Medium context
Immune
VIP
A vasoactive intestinal peptide associated with neuroimmune and inflammatory signaling discussions.
Investigational Early evidence 1 alias
Trials 54PubMed 1K Medium context
🧪 Hormone Peptides
Hormone
Hormone-linked signaling compounds that do not fit cleanly into the GH or metabolic buckets.
26
🔥 HOT
Weight Loss
Amycretin
A Novo Nordisk investigational co-agonist targeting GLP-1 and amylin pathways, now closely watched as a next-wave obesity candidate.
Investigational Promising evidence 1 alias
Also in Hormone
Trials 21PubMed 17 Medium context
🔥 HOT
Other
Brenipatide
A Lilly investigational peptide candidate being studied in alcohol use disorder, mood disorders, and other craving-linked conditions.
Investigational Early evidence 1 alias
Also in Hormone
Trials 16 Low context
🔥 HOT
Weight Loss
CagriSema
A Novo Nordisk investigational combination of cagrilintide and semaglutide, designed to pair amylin and GLP-1 pathways in obesity.
Investigational Promising evidence
Also in Hormone
Trials 30PubMed 44 Medium context
🔥 HOT
Weight Loss
Eloralintide
A selective amylin receptor agonist from Eli Lilly that has moved into Phase 3 obesity trials.
Investigational Promising evidence 1 alias
Also in Hormone
Trials 18PubMed 6 Medium context
🔥 HOT
Weight Loss
Mazdutide
A GLP-1 and glucagon dual agonist developed with Innovent and Lilly, notable for obesity data and approval progress in China.
Investigational Promising evidence 2 aliases
Also in Hormone
Trials 36PubMed 46 Medium context
🔥 HOT
Weight Loss
Pemvidutide
A balanced GLP-1 and glucagon dual agonist from Altimmune with obesity and liver-disease relevance.
Investigational Promising evidence 1 alias
Also in Hormone
Trials 15PubMed 15 Medium context
🔥 HOT
Weight Loss
Petrelintide
A long-acting amylin analog from Zealand Pharma being developed for obesity and overweight.
Investigational Promising evidence
Also in Hormone
Trials 6PubMed 4 Low context
Hormone
Apelin
An endogenous peptide ligand for the APJ receptor with cardiovascular and metabolic research relevance.
Investigational Promising evidence
Also in Other
Trials 65PubMed 3K Medium context
Hormone
Avexitide
A GLP-1 receptor antagonist, also known as exendin 9-39, now in Phase 3 for post-bariatric hypoglycemia.
Investigational Promising evidence 1 alias
Also in Other
Trials 56PubMed 528 Medium context
Other
Cortistatin
A neuropeptide related to somatostatin that has been studied for anti-inflammatory, neuroendocrine, and cardiovascular effects.
Investigational Preclinical evidence 1 alias
Also in Hormone · Immune
Trials 727PubMed 8K Medium context
Hormone
Dasiglucagon
A glucagon analog approved in the United States as Zegalogue for severe hypoglycemia.
FDA Approved Established evidence 1 alias
FDATrials 21PubMed 47 High context
Hormone
Gonadorelin
A GnRH analogue tied to endocrine signaling, diagnostic history, and fertility-related peptide discussions.
Research Market Preclinical evidence 2 aliases
Trials 150PubMed 295 Medium context
Growth Hormone
Hexarelin
A growth hormone secretagogue and ghrelin-receptor agonist that remains a familiar legacy name in GH-peptide stacks.
Research Market Preclinical evidence
Also in Hormone
PubMed 289 Low context
Hormone
Kisspeptin
A reproductive-axis signaling peptide studied for its role in GnRH release and fertility-related endocrinology.
Investigational Promising evidence
Trials 45PubMed 3.3K Medium context
Hormone
Lanreotide
A long-acting somatostatin analog marketed as Somatuline Depot and used in neuroendocrine and acromegaly-related care.
FDA Approved Established evidence 2 aliases
FDATrials 124PubMed 1.2K High context
Skin & Cosmetic
Melanotan I
A melanocortin peptide analogue tied to pigmentation and photoprotection research, and closely related to the approved drug afamelanotide.
FDA Approved Established evidence 2 aliases
Also in Hormone
FDATrials 23PubMed 119 High context
Skin & Cosmetic
Melanotan II
A melanocortin analogue commonly discussed for tanning and cosmetic interest but not approved as an FDA drug.
Research Market Promising evidence
Also in Hormone
Trials 1PubMed 197 Low context
Hormone
Metreleptin
An FDA-approved leptin analog used in rare metabolic disease, best known in the United States as Myalept.
FDA Approved Established evidence 1 alias
FDATrials 41PubMed 247 High context
Hormone
Octreotide
A somatostatin analog widely used in endocrine and neuroendocrine medicine, and one of the most important approved peptide drugs missing from many peptide libraries.
FDA Approved Established evidence 2 aliases
FDATrials 377PubMed 9.6K High context
Weight Loss
Oxyntomodulin
A gut hormone that acts on GLP-1 and glucagon-related pathways and helped shape the modern obesity-peptide conversation.
Investigational Early evidence 1 alias
Also in Hormone
Trials 54PubMed 493 Medium context
Hormone
Oxytocin
A peptide hormone used in FDA-approved medical settings but also frequently reframed in wellness and research-market discussions.
FDA Approved Established evidence 1 alias
FDATrials 1.4KPubMed 29.2K High context
Hormone
Pasireotide
An FDA-approved somatostatin analog marketed as Signifor, used in Cushing's disease and related endocrine settings.
FDA Approved Established evidence 2 aliases
FDATrials 87PubMed 760 High context
Weight Loss
Peptide YY
A satiety-linked gut hormone that has long been studied in obesity and appetite regulation.
Investigational Promising evidence 2 aliases
Also in Hormone
Trials 708PubMed 4.4K Medium context
Hormone
PT-141
A melanocortin peptide best known in regulated medicine as bremelanotide and in the research market as PT-141.
FDA Approved Established evidence 2 aliases
Also in Skin & Cosmetic
FDATrials 10PubMed 111 High context
Weight Loss
Setmelanotide
An FDA-approved MC4R agonist marketed as Imcivree for specific rare genetic forms of obesity.
FDA Approved Established evidence 2 aliases
Also in Hormone
FDATrials 30PubMed 205 High context
Hormone
Vosoritide
An FDA-approved C-type natriuretic peptide analog marketed as Voxzogo for achondroplasia.
FDA Approved Established evidence 1 alias
FDATrials 18PubMed 104 High context
• Other Peptides
Other
Useful overflow for compounds that do not belong to the main editorial buckets.
12
🔥 HOT
Other
Brenipatide
A Lilly investigational peptide candidate being studied in alcohol use disorder, mood disorders, and other craving-linked conditions.
Investigational Early evidence 1 alias
Also in Hormone
Trials 16 Low context
🔥 HOT
Nootropic
Dihexa
A high-curiosity neurotrophic research peptide discussed for cognition and synaptogenesis, but still lacking real clinical development.
Research Market Preclinical evidence 2 aliases
Also in Other
PubMed 17 Low context
🔥 HOT
Muscle Growth
Follistatin 344
A myostatin-linked muscle-growth name that remains popular in research-market and performance discussions despite limited conventional therapeutic development.
Research Market Promising evidence 2 aliases
Also in Other
Trials 75PubMed 2.9K Medium context
Metabolic
5-Amino-1MQ
A small-molecule NNMT inhibitor studied for its potential to increase cellular energy expenditure and reduce fat accumulation by blocking nicotinamide N-methyltransferase.
Research Market Preclinical evidence 1 alias
Also in Other
PubMed 3 Low context
Hormone
Apelin
An endogenous peptide ligand for the APJ receptor with cardiovascular and metabolic research relevance.
Investigational Promising evidence
Also in Other
Trials 65PubMed 3K Medium context
Hormone
Avexitide
A GLP-1 receptor antagonist, also known as exendin 9-39, now in Phase 3 for post-bariatric hypoglycemia.
Investigational Promising evidence 1 alias
Also in Other
Trials 56PubMed 528 Medium context
Other
Cortistatin
A neuropeptide related to somatostatin that has been studied for anti-inflammatory, neuroendocrine, and cardiovascular effects.
Investigational Preclinical evidence 1 alias
Also in Hormone · Immune
Trials 727PubMed 8K Medium context
Longevity
FOXO4-DRI
A D-retro-inverso peptide designed to disrupt the FOXO4-p53 interaction in senescent cells, studied as a senolytic agent that selectively induces apoptosis in aging cells.
Research Market Preclinical evidence 2 aliases
Also in Other
PubMed 18 Low context
Neuroprotection
PE-22-28
A seven-amino acid fragment of the neuropeptide spadin, studied as a TREK-1 channel blocker with potential antidepressant-like effects in preclinical models.
Research Market Preclinical evidence 2 aliases
Also in Other
PubMed 1 Low context
Other
PNC-27
A synthetic peptide containing an HDM2-binding domain and a membrane-penetrating sequence, studied for selective cytotoxicity against cancer cells expressing surface-bound HDM2.
Research Market Preclinical evidence
PubMed 23 Low context
Other
Prostamax
A synthetic tetrapeptide (Lys-Glu-Asp-Pro) from the Khavinson bioregulator family, studied for prostatic tissue bioregulation and geroprotective effects.
Research Market Preclinical evidence 2 aliases
Also in Longevity
PubMed 9 Low context
Other
Testagen
A synthetic tetrapeptide (Lys-Glu-Asp-Gly) from the Khavinson bioregulator family, studied for testicular tissue bioregulation and age-related hormonal support.
Research Market Early evidence 2 aliases
Also in Longevity
Trials 1PubMed 13 Low context
No peptide profiles match that filter yet.
Try a broader category, clear the search, or switch back to all statuses.